Edition:
United Kingdom

AMAG Pharmaceuticals Inc (AMAG.OQ)

AMAG.OQ on NASDAQ Stock Exchange Global Select Market

10.32USD
6:56pm BST
Change (% chg)

$-0.37 (-3.46%)
Prev Close
$10.69
Open
$10.72
Day's High
$10.72
Day's Low
$10.17
Volume
134,715
Avg. Vol
330,223
52-wk High
$25.15
52-wk Low
$6.81

About

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia... (more)

Overall

Beta: 0.91
Market Cap(Mil.): $661.66
Shares Outstanding(Mil.): 35.29
Dividend: --
Yield (%): --

Financials

  AMAG.OQ Industry Sector
P/E (TTM): -- 29.89 32.67
EPS (TTM): -1.39 -- --
ROI: -2.17 14.89 14.48
ROE: -4.83 16.01 15.78

Amag's female libido injectable therapy to sell at $899

Amag Pharmaceuticals Inc's treatment to boost sexual desire in premenopausal women will be offered at $899 and is the only injectable drug on the market for hypoactive sexual desire disorder (HSDD).

06 Aug 2019

UPDATE 1-Amag's female libido injectable therapy to sell at $899

Aug 6 Amag Pharmaceuticals Inc's treatment to boost sexual desire in premenopausal women will be offered at $899 and is the only injectable drug on the market for hypoactive sexual desire disorder (HSDD).

06 Aug 2019

Amag's female libido injectable therapy to sell at $899

Aug 6 Amag Pharmaceuticals Inc's treatment to boost sexual desire in premenopausal women will be offered at $899 and is the only injectable drug on the market for the condition.

06 Aug 2019

FDA approves drug for loss of sexual desire in women

The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceuticals' drug to restore sexual desire in premenopausal women, the latest attempt to come up with a therapy that some have dubbed as "female Viagra".

21 Jun 2019

UPDATE 2-FDA approves drug for loss of sexual desire in women

June 21 The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceuticals' drug to restore sexual desire in premenopausal women, the latest attempt to come up with a therapy that some have dubbed as "female Viagra".

21 Jun 2019

FDA approves drug for loss of female sexual desire

June 21 The U.S. Food and Drug Administration on Friday approved Palatin Technologies Inc and Amag Pharmaceuticals Inc's drug to restore sexual desire in premenopausal women, Amag said.

21 Jun 2019

BUZZ-U.S. STOCKS ON THE MOVE-Eventbrite, oil stocks, Big Lots, Exxon Mobil, Costco

* Eikon search string for individual stock moves: * The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi * The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh U.S. stocks were on pace for their fifth day of losses on Friday, after weak U.S. jobs data in February added to concerns over cooling global growth that was sparked by a sharp fall in China's exports and a prolonged slowdown in the eurozone. At 1:55 p.m. ET, the Dow Jones Industrial Average was down 0.56 perc

08 Mar 2019

BUZZ-U.S. STOCKS ON THE MOVE-Eventbrite, banks, oil stocks, Big Lots, Exxon Mobil, DropCar

* Eikon search string for individual stock moves: * The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi * The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street's main indexes fell on Friday, after data showed U.S. job growth almost stalled in February, adding to concerns of a slowdown in global growth sparked by weak China export data and a prolonged slowdown in the eurozone. At 11:42 ET, the Dow Jones Industrial Average was down 0.45 percent at 25,358.99

08 Mar 2019

BUZZ-U.S. STOCKS ON THE MOVE-Eventbrite, Banks, Big Lots, ExxonMobil

* Eikon search string for individual stock moves: * The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi * The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street declined on Friday after data showed U.S. job growth almost stalled in February, adding to concerns of a slowdown in global growth sparked by weak China export data and a prolonged slowdown in eurozone. At 10:06 ET, the Dow Jones Industrial Average was down 0.72 percent at 25,290.54. The S&P 500

08 Mar 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates